On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash Plus: Highlights from an event with ex-regulator Richard Pazdur

https://www.statnews.com/2026/01/13/jpm-2026-day-2-top-stories-pazdur-travere-oz-pande/ By Matthew Herper, Elaine Chen, Allison DeAngelis, and Adam FeuersteinJan. 13, 2026 Watch: At JPM, former drug regulator Richard Pazdur rings the alarm about politics at FDA Speaking at a STAT event, the longtime official expressed deep concern about the agency https://www.statnews.com/2026/01/13/jpm-2026-richard-pazdur-full-session-video-future-of-fda/ By STAT StaffJan. 13, 2026 Pazdur warns that politics, ‘chaos’ are damaging FDA Veteran drug regulator, who left the agency last month, says industry hasn’t fully realized extent of the issues https://www.statnews.com/2026/01/13/richard-pazdur-jpm-fda-chaos-at-agency-stat-event/ By Elaine ChenJan. 13, 2026 Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.